DJIA 18,081.84 -81.15 -0.45%
NASDAQ 5,089.99 -16.61 -0.33%
S&P 500 2,116.11 -7.37 -0.35%
market minute promo

The Medicines Company (NASDAQ: MDCO)

27.94 0.31 (1.12%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MDCO $27.94 1.12%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $27.13
Previous Close $27.63
Daily Range $26.94 - $28.10
52-Week Range $19.92 - $32.44
Market Cap $1.9B
P/E Ratio -81.26
Dividend (Yield) $0.00 (0.0%)
Volume 315,996
Average Daily Volume 887,005
Current FY EPS $0.10

Sector

Healthcare

Industry

Drug Makers

The Medicines Company (MDCO) Description

A pharmaceutical company provides innovative, cost effective acute care hospital products to the worldwide hospital marketplace. Website: http://www.themedicinescompany.com/

News & Commentary

Alnylam Pharmaceuticals, Inc.'s Five-Year Plan

The biotech updated investors on its Alnylam 2020 plan during its first-quarter earnings announcement.

Alnylam's Q1 Loss Narrower than Expected, Confirms Guidance - Analyst Blog

The Medicines Co. Incurs Loss in Q1, Angiomax Sales Fall - Analyst Blog

The Medicines (MDCO) Clive A. Meanwell on Q1 2015 Results - Earnings Call Transcript

The Medicines (MDCO) Q1 2015 Results - Earnings Call Webcast

Health Care Sector Update for 05/01/2015: LPNT, MDCO

The Zacks Analyst Blog Highlights: Amgen, Medicines, Athersys and Alnylam - Press Releases

Biotech Stock Roundup: Amgen Starts Earnings Season on Strong Note, Setbacks for Ampio & Athersys -

Biotech Stock Roundup: Amgen Starts Earnings Season on Strong Note, Setbacks for Ampio & Athersys - Analyst Blog

The Medicines Co.'s New Minocin Formulation Approved - Analyst Blog

The Medicines Co.'s New Minocin Formulation Approved - Analyst Blog

Insider Trading Alert - AMP, MDCO And MEMP Traded By Insiders

See More MDCO News...

MDCO's Top Competitors

MDCO $27.94 (1.12%)
Current stock: MDCO
JNJ $101.06 (-0.07%)
Current stock: JNJ
NVS $103.70 (0.16%)
Current stock: NVS
RHHBY $37.36 (1.26%)
Current stock: RHHBY